Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study
2024 · Clinical Genitourinary Cancer · 6 citations
https://doi.org/10.1016/j.clgc.2024.102278
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
77
Citations
4
h-index
3
i10-index
Dora Niedersuess‐Beke is an academic researcher from Wilhelminen Hospital. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Colorectal Cancer Treatments and Studies & Renal cell carcinoma treatment. The author has an h-index of 4, co-authored 13 publications.
ORCID: 0000-0003-0544-5773Click to start Chat